Literature DB >> 1378016

CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion.

W J Karpus1, K E Gould, R H Swanborg.   

Abstract

We have previously demonstrated that CD4+ suppressor T cells (Ts) inhibit the secretion of interferon (IFN)-gamma, but not interleukin (IL)-2, by effector cells of experimental autoimmune encephalomyelitis (EAE). Moreover, CD4+ Ts appear to regulate IFN-gamma by secretion of transforming growth factor-beta. We now show that CD4+ Ts produce a lymphokine with IL-4 activity in response to a determinant associated with EAE effector cells. CD4+ Ts do not proliferate or secrete IFN-gamma, IL-2, or IL-4 in response to myelin basic protein, nor do CD4+ Ts proliferate or secrete IL-2 when co-cultured with irradiated EAE effector cells. Rather, CD4+ Ts secrete IL-4 when co-cultured with either irradiated effector spleen cells or irradiated encephalitogenic line cells. CD4+ Ts do not secrete IL-4 in response to OVA-primed spleen cells, suggesting that the suppressor cells recognize a determinant specific to encephalitogenic T cells. Furthermore, CD4+ Ts secrete IL-4 when cultured with synthetic T cell receptor (TcR) V beta 8, but not TcR V beta 14 peptide, in the presence of antigen-presenting cells. This response is major histocompatibility complex class II restricted as demonstrated by inhibition of the response with anti-class II monoclonal antibody. These results suggest that CD4+ Ts recognize a determinant associated with TcR on the surface of EAE effector cells and respond by secreting IL-4, in a manner analogous to the Th2 lymphocyte subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378016     DOI: 10.1002/eji.1830220714

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  T-cell receptor V beta repertoire of L3T4+ regulatory T cells in anti-L3T4 antibody-induced tolerant NOD mice.

Authors:  A Sakamoto; M Furukawa; I Iwamoto; T Koike; H Tomioka; T Sumida
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

3.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

Review 4.  Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.

Authors:  Tanuja Chitnis; Samia J Khoury
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.

Authors:  A Kuhröber; R Schirmbeck; J Reimann
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

Authors:  M K Shaw; J B Lorens; A Dhawan; R DalCanto; H Y Tse; A B Tran; C Bonpane; S L Eswaran; S Brocke; N Sarvetnick; L Steinman; G P Nolan; C G Fathman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

7.  Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.

Authors:  Evilin Naname Komegae; Tais Aparecida Matozo Souza; Lidiane Zito Grund; Carla Lima; Monica Lopes-Ferreira
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

8.  The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease.

Authors:  V Kumar; E E Sercarz
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

9.  Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.

Authors:  Cristina Musselli; Svetlana Daverio-Zanetti; Maurizio Zanetti
Journal:  J Immune Based Ther Vaccines       Date:  2004-11-12

10.  The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.

Authors:  M Mustafa; C Vingsbo; T Olsson; A Ljungdahl; B Höjeberg; R Holmdahl
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.